Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)

作者：Sun, Juxian; Guo, Rongping; Bi, Xinyu; Wu, Mengchao; Tang, Zhaoyou; Lau, Wan Yee; Zheng, Shusen; Wang, Xuehao; Yu, Jinming; Chen, Xiaoping; Fan, Jia; Dong, Jiahong; Chen, Yongjun; Cui, Yunfu; Dai, Chaoliu; Fang, Chihua; Feng, Shuang; Ji, Zhili; Jia, Weidong; Jia, Ningyang; Li, Gong; Li, Jing; Li, Qiu; Li, Jiangtao; Liang, Tingbo; Liu, Lianxin; Lu, Shichun; Lv, Yi; Mao, Yilei; Meng, Yan; Meng, Zhiqiang; Shen, Feng; Shi, Jie; Sun, Huichuan; Tao, Kaishan; Teng, Gaojun; Wan, Xuying; Wen, Tianfu

来源：Liver Cancer, 2022, 11(4): 315-328.

DOI：10.1159/000523997

• Hepatocellular carcinoma
• Portal vein tumor thrombus
• Multidisciplinary therapy
• Guideline

Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the first version of the guideline in 2016 and revised in 2018. Over the past several years, many new evidences for the treatment of PVTT become available, especially for the advent of new targeted drugs and immune checkpoint inhibitors which have further improved the prognosis of PVTT. So, the Chinese Association of Liver Cancer and Chinese Medical Doctor Association revised the 2018 version of the guideline to adapt to the development of PVTT treatment. Future treatment strategies for HCC with PVTT in China would depend on new evidences from more future clinical trials.

• 单位
  山东大学; 1; 中山大学; 中国医学科学院北京协和医院; 内蒙古医学院; 中国人民解放军第四军医大学; 华中科技大学; 吉林大学; 清华大学; 青岛大学; 复旦大学; 浙江大学; 中国医科大学; 南方医科大学; 西安交通大学; 上海交通大学; 6; 广州医学院; 哈尔滨医科大学; 四川大学